Skip to content
Loading Events

« All Events

Review period expiry for use of 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)

4th January 2033

4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)

  • 5 uses applied for by Octapharma AB and 4 other co-applicants

Reference of the decision

Date of decision

Substance name

Holder of the authorisation

Authorisation number

Authorised use

Date of expiry of review period

C(2022) 1506

16 March 2022

4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated

(4-tert-OPnEO)

EC No: -, CAS No:-

Octapharma AB, Lars Forssells gata 23, SE-11275 Stockholm, Sweden

Octapharma

Produktionsgesel schaft Deutschland mbH, Wolfgang- Marguerre-Allee 1, 31832 Springe, Germany

Octapharma S.A.S. 72 rue du Maréchal Foch, 67381 Lingolsheim, France

REACH/22/5/0

REACH/22/5/1

REACH/22/5/2

REACH/22/5/3

As detergent for a virus inactivation step (solvent/detergent treatment) during the manufacture of plasma-derived and recombinant medicinal products

4 January 2033

Details

Date:
4th January 2033
Event Category:
Event Tags:

Organiser

European Commission
View Organiser Website